[1]刘海波,卢 佩,李春梦,等.肾病综合征患者凝血指标检测价值分析*[J].陕西医学杂志,2020,49(4):506-509.
　LIU Haibo,LU Pei,LI Chunmeng,et al.Value of several coagulation indexes in patients with nephrotic syndrome[J].,2020,49(4):506-509.
点击复制

肾病综合征患者凝血指标检测价值分析*
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年4期
页码:
506-509
栏目:
临床检验
出版日期:
2020-04-05

文章信息/Info

Title:
Value of several coagulation indexes in patients with nephrotic syndrome
文章编号:
DOI:10.3969/j.issn.10007377.2020.04.030
作者:
刘海波1; 卢 佩2; 李春梦1; 朱兵兵2; 白 妮3△
1.陕西省中医医院(西安710003); 2.空军军医大学西京医院检验科(西安 710032); 3.西安市中心医院检验科(西安 710004)
Author(s):
LIU Haibo; LU Pei; LI Chunmeng; et al.
Shaanxi Traditional Chinese Medicine Hospital(Xi'an 710003)
关键词:
纤维蛋白原;  D-二聚体;  肾病综合征;  纤维蛋白(原)降解产物;  凝血酶原时间;  活化部分凝血活酶时间
Keywords:
Fibrinogen;  D-dimer;  Nephritic syndrome;  Fibrin(-ogen)degradation products;  Prothrombin time;  Activated partial thromboplastin time
分类号:
R692
文献标志码:
A
摘要:
目的:探讨D-二聚体、凝血酶原时间(PT)、纤维蛋白(原)降解产物(FDP)、纤维蛋白原(FIB)、活化部分凝血活酶时间(APTT)这五项凝血指标水平与肾病综合征的关联和临床应用价值。方法:对138例肾病综合征患者,130例肾小球肾炎患者和136例健康者的凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原、D-二聚体和纤维蛋白(原)降解产物进行检测,并进行比较。结果:肾病综合征患者组的FDP、FIB和D-二聚体检测高于肾小球肾炎组和健康对照组(P<0.05); 肾病综合征组的D-二聚体、FDP阳性率分别为86.8%和68.4%高于肾小球肾炎组和健康对照组(P<0.05); 肾病综合征组的PT和APTT结果低于肾小球肾炎组和健康对照组,两组比较差异无统计学意义(P>0.05); 肾小球肾炎组D-二聚体、FDP、FIB、PT和APTT与健康对照组比较差异无统计学意义(P>0.05)。结论:D-二聚体、纤维蛋白(原)降解产物和纤维蛋白原的水平可以提示肾病综合征患者的血凝状态和血栓风险,有利于患者的合理诊疗及血栓预防。
Abstract:
Obsjective:To investigate the relationship between the levels of D-dimer,prothrombin time(PT),fibrin(-ogen)degradation products(FDP),fibrinogen(FIB),activated partial thromboplastin time(APTT)and nephrotic syndrome and their clinical application value. Methods:The PT,APTT,FIB,D-dimer and FDP of 138 patients with nephrotic syndrome,130 patients with glomerulonephritis and 136 healthy people were detected and compared. Results:The results of D-dimer,FDP and FIB of nephrotic syndrome group were significantly higher than those of glomerulonephritis group and healthy control group(P< 0.05). The positive rates of D-dimer and FDP in nephrotic syndrome group were 86.8% and 68.4% respectively,which were higher than those in glomerulonephritis group and healthy control group(P<0.05). The results of PT and APTT in nephrotic syndrome group were lower than those in glomerulonephritis group and healthy control group with no statistical difference(P>0.05). There was no statistical difference in D-dimer,FDP,FIB,PT and APTT between glomerulonephritis group and healthy control group(P>0.05). Conclusion:The levels of D-dimer,FDP and FIB can indicate the coagulation status and thrombus risk of patients with nephrotic syndrome,which is beneficial to the reasonable diagnosis and treatment of patients and thrombus prevention.

参考文献/References:

[1] Zhu X,Li S,Zhang Q,et al. Correlation of increased Th17/Treg cell ratio with endoplasmic reticulum stress in chronic kidney disease[J]. Medicine(Baltimore),2018,97(20):e10748.
[2] Zhang L,Wang F,Wang L,et al. Prevalence of chronic kidney disease in China:a cross-sectional survey[J]. Lancet,2012,379(9818):815-822.
[3] Wu J,Guo N,Chen X,et al. Low triiodothyronine syndrome is associated with platelet function in patients with nephrotic syndrome[J]. Rev Assoc Med Bras(1992),2019,65(7):988-992.
[4] 卢 佩,刘海波,丁振若,等. 尿细胞形态学检测辅助诊断肾病综合征1例分析[J]. 国际检验医学杂志,2015,36(2):286-287.
[5] 马骏骉,程 虹,王国勤,等. 临床实验室指标判断肾病综合征患者低血容量的诊断价值[J]. 中华肾脏病杂志,2017,33(7):504-509.
[6] Barbano B,Gigante A,Amoroso A,et al. Thrombosis in nephrotic syndrome[J]. Semin Thromb Hemost,2013,39(5):469-476.
[7] 刘海波,卢 佩,朱兵兵,等. 慢性肾衰竭患者凝血指标分析[J]. 检验医学与临床,2019,16(19):2832-2834.
[8] 赵 威,田 笑,陈 欣,等. STAGO STA-R全自动血凝仪性能验证与评价[J]. 血栓与止血学,2016,22(1):74-76.
[9] 刘 娜,赵卫华. StagoSTA-R全自动血凝分析仪性能验证与评价[J]. 国际检验医学杂志,2017,38(5):654-656.
[10] Mirrakhimov AE,Ali AM,Barbaryan A,et al. Primary nephrotic syndrome in adults as a risk factor for pulmonary embolism:an up-to-date review of the literature[J]. Int J Nephrol,2014:916760.
[11] 胡 杰,杨 洁,孙脊峰. 膜性肾病凝血紊乱机制及治疗进展[J]. 解放军医学杂志,2019,44(3):266-270.
[12] 崔为英.肾病综合征高凝状态下并发下肢静脉血栓44例治疗分析[J].陕西医学杂志,2015,44(5):590-592.
[13] Gordon-Cappitelli J,Choi MJ. Prophylactic anticoagulation in adult patients with nephrotic syndrome[J]. Clin J Am Soc Nephrol,2020,15(1):123-125..
[14] 黄宏伟. 临产孕妇凝血指标检测的临床意义[J]. 中国民康医学,2016,28(22):48-49.
[15] 王 晶,方柯南,孙 洁. 防己黄芪汤治疗小儿肾病综合征疗效及对患儿肾功能、凝血系统的影响[J].陕西中医,2019,40(9):1183-1186.
[16] 吕海燕,李 瑛. 肾病综合征患者血清β2-微球蛋白视黄醇结合蛋白水平及凝血功能变化及其意义[J]. 中国药物与临床,2019,19(12):2015-2016.
[17] 戴海英,薛晓婕,汪宏良. 血浆凝血酶激活的纤溶抑制物与肾病综合征的关系研究[J]. 国际检验医学杂志,2018,39(14):1725-1729.
[18] 程乐宁. 肾病综合征患者血清β2-MG、肾功能指标、凝血功能指标测定及其相关性分析[J]. 四川解剖学杂志,2019,4:10-11.
[19] 陆 胜,季雄娟. Ⅱ型糖尿病患者血浆纤维蛋白原及D-二聚体检测的临床应用[J]. 检验医学与临床,2013,10(20):2729-2730.
[20] 王玉艳,李会荣. 对肾病综合征患者几项凝血指标的观察[J]. 中国医药指南,2014,12(5):105-106.
[21] 童红斌. 肾病综合征患者凝血功能检测的临床意义[J]. 中国医药指南,2012,10(34):192-193.
[22] Bull KR,Mason T,Rimmer A J,et al. Next-generation sequencing to dissect hereditary nephrotic syndrome in mice identifies a hypomorphic mutation in Lamb2 and models Pierson's syndrome[J]. J Pathol,2014,233(1):18-26.

相似文献/References:

[1]王家林,田 伟,陈耀华,等.食管鳞状细胞癌患者术前血清纤维蛋白原水平与病理特征及预后关系探讨*[J].陕西医学杂志,2020,49(5):630.
　WANG Jialin,TIAN Wei,CHEN Yaohua,et al.Correlation between preoperative serum fibrinogen and pathological characteristics and prognosis in patients with esophageal squamous cell carcinoma[J].,2020,49(4):630.
[2]周辰光,范立壮,刘 松,等.高位结扎联合氰基丙烯酸酯封闭治疗对大隐静脉曲张患者血清D-二聚体、C反应蛋白表达及VCSS评分的影响*[J].陕西医学杂志,2020,49(11):1489.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.031]
　ZHOU Chenguang,FAN Lizhuang,LIU Song,et al.Effects of high ligation combined with cyanoacrylate sealing on expressions of D-dimer,C-reactive protein and VCSS score in patients with varicose great saphenous vein[J].,2020,49(4):1489.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.031]
[3]李春梦,王海峰,卢 佩,等.糖尿病肾病患者D-二聚体、纤维蛋白原、胱抑素C检测及临床意义*[J].陕西医学杂志,2020,49(11):1503.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.035]
　LI Chunmeng,WANG Haifeng,LU Pei,et al.Detection and clinical significance of D-dimer,fibrinogen,cystatin C in patients with diabetic nephropathy[J].,2020,49(4):1503.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.035]
[4]董伟伟,吴彩兰.甲状腺功能亢进症与血栓形成相关性研究进展[J].陕西医学杂志,2021,50(2):251.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.032]
　DONG Weiwei,WU Cailan.Research progress on the relationship between hyperthyroidism and thrombosis[J].,2021,50(4):251.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.032]
[5]杨 帆,高 盼.血小板参数、D-二聚体在妊娠高血压综合征早期肾损伤患者中的表达及临床意义[J].陕西医学杂志,2021,50(4):413.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.007]
　YANG Fan,GAO Pan.Expression and clinical significance of platelet parameters and D-dimer in patients with early-stage renal injury in pregnancy-induced hypertension syndrome[J].,2021,50(4):413.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.007]
[6]申辽辽,贺 丽.血浆纤维蛋白原、血小板计数检测在胃癌诊断与预后评估中的临床意义[J].陕西医学杂志,2021,50(4):489.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.028]
[7]魏 娜,张晓智.盐酸安罗替尼或甲磺酸阿帕替尼治疗晚期实体恶性肿瘤疗效及对患者凝血功能的影响[J].陕西医学杂志,2021,50(7):871.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.027]
[8]田 原,陈伟志,牛玉军.腹主动脉瘤患者D-二聚体水平及其与腹主动脉瘤最大直径、腔内血栓厚度相关性分析[J].陕西医学杂志,2022,51(3):325.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.014]
　TIAN Yuan,CHEN Weizhi,NIU Yujun.D-dimer level in patients with abdominal aortic aneurysm and its correlation with maximum diameter of abdominal aortic aneurysm and intraluminal thrombus thickness[J].,2022,51(4):325.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.014]
[9]肖 翔,彭 飞,周 瑞.血清N端脑钠肽前体、肌红蛋白、D-二聚体水平与冠心病患者心室重构和主要心血管不良事件关系分析[J].陕西医学杂志,2023,52(6):697.[doi:DOI:10.3969/j.issn.1000-7377.2023.06.013]
[10]吕 魁,孙俊峰,杨健鹰.血清C反应蛋白、降钙素原、D-二聚体在急性胰腺炎患者中的表达及与严重程度床边指数和肺损伤的相关性[J].陕西医学杂志,2023,52(10):1375.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.020]
[11]刘海波,许建秦,李春梦,等.胱抑素C和甘油三酯检测对糖尿病肾病的早期诊断价值研究[J].陕西医学杂志,2021,50(1):96.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.026]
　LIU Haibo,XU Jianqin,LI Chunmeng,et al.Value of cystatin C and triglyceride in early diagnosis of diabetic nephropathy[J].,2021,50(4):96.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.026]
[12]李 凯.血清D-二聚体、纤维蛋白原检测对冠心病非体外循环冠状动脉旁路移植术后缺血事件风险预测价值[J].陕西医学杂志,2021,50(7):854.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.022]

备注/Memo

备注/Memo:
*西安市科技局项目[201805103YX11SF37(15)]
更新日期/Last Update: 2020-04-13